NCT04818112

Brief Summary

Childhood adversity affects almost two-thirds of the US population, is a major risk factor for the leading causes of disease and increases US economic health burdens. Childhood adversity also alters biologic systems, such as the oxytocin hormone, that can affect attachment behavior. This innovative study has the potential to advance science and improve mother-infant interaction by testing an early life, home-based, multisensory behavioral intervention (called ATVV), targeting the oxytocin system, to promote synchronous early mother-infant interaction, especially critical for mothers who have experienced childhood adversity. This two-group randomized clinical trial will test the ATVV's effect on oxytocin system function and quality of mother-infant interaction. The investigators will enroll 250 first-time healthy mothers carrying a single baby who have a history of childhood adversity, and obtain baseline data in their third trimester of pregnancy. Soon after birth (before hospital discharge), mothers (and babies) who continue to be eligible are randomized into the intervention group and taught to give ATVV daily for 3 months, or randomized into the Attention Control education group and taught safe infant care. After birth, the investigators check-in frequently with mothers through weekly phone calls. There are 3 study visits at 1, 2 and 3 months after birth that include survey questions and collection of maternal blood and infant saliva. Mothers and babies are also video-recorded at 3 months after birth for 4 minutes to assess mother-infant interaction. The investigators follow-up with a phone call at 6 months after birth. While both groups will benefit from the content and attention the investigators give mothers, the investigators hypothesize that, compared to the education group, mothers and infants in the intervention group will have improved oxytocin system function and more synchronous mother-infant interaction.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
262

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2021

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 23, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 26, 2021

Completed
4 months until next milestone

Study Start

First participant enrolled

July 12, 2021

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 8, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 17, 2024

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

August 13, 2025

Completed
Last Updated

August 13, 2025

Status Verified

July 1, 2025

Enrollment Period

2.7 years

First QC Date

March 23, 2021

Results QC Date

April 30, 2025

Last Update Submit

July 25, 2025

Conditions

Keywords

OxytocinDNA methylationMassageMothersInfantAdverse childhood experiencesMother-infant interactionMaternal behaviorInfant behaviorReceptor, oxytocinRandomized controlled trial

Outcome Measures

Primary Outcomes (1)

  • Mother-Infant Synchrony, Gaze and Affect

    Video-recordings of mothers freely interacting with their infant were micro-coded second by second for the number of seconds of mother-infant synchrony over 180 seconds. Behaviors are categorized into mutually exclusive codes. The most robust behavior categories for mothers and infants (individually and in synchrony) are gaze and affect. Maternal gaze consisted of mother's gaze to infant's face, to infant's body, to object or environment, and gaze aversion. Infant gaze consisted of gaze to mother, gaze to object or environment, and gaze aversion. Maternal affect consisted of positive, neutral, and negative affective expression. Infant affect consisted of high positive (laugh, giggle, smile), positive (smile, bright face), negative (sad face, occasional whimper), high negative (cry, strong whining), or neutral.

    84 +/- 7days from birth (approximately 3 months after birth)

Secondary Outcomes (6)

  • Mother-Infant Synchrony, Vocalization and Touch

    84 +/- 7days from birth (approximately 3 months after birth)

  • Oxytocin Receptor Gene DNA Methylation Reflecting Epigenetic Marks

    Baseline at 31weeks +/- 2 weeks gestation and every 28 days +/- 7 days from birth to 3 months

  • Oxytocin Receptor Gene Expression

    Baseline at 31weeks +/- 2 weeks gestation and every 28 days +/- 7 days from birth to 3 months

  • Oxytocin Receptor Protein

    Baseline at 31weeks +/- 2 weeks gestation and every 28 days +/- 7 days from birth to 3 months

  • Oxytocin Peptide, Maternal Plasma

    Baseline at 31weeks +/- 2 weeks gestation and every 28 days +/- 7 days from birth to 3 months

  • +1 more secondary outcomes

Study Arms (2)

Behavioral ATVV intervention

EXPERIMENTAL

A multi-sensory behavioral intervention that includes auditory, tactile, visual and vestibular (ATVV) stimulation contingent upon infant cues.

Behavioral: ATVV

Attention control

ACTIVE COMPARATOR

An attention control group that receives education on safe infant care and the same amount of attention as the intervention group.

Behavioral: Attention control

Interventions

ATVVBEHAVIORAL

A 15-minute behavioral intervention that mothers administer once daily to their infant for 3 months providing Auditory, Tactile, Visual, and Vestibular (ATVV) stimulation. Multisensory stimuli are presented in gradual progression. Mother-infant engagement is attempted throughout ATVV so that mothers learn to identify, interpret and adapt to their infants cues. ATVV can be given without eye to eye gaze making it appropriate for newborns. ATVV is offered contingent on infant cues to promote self-regulation and withdrawn if any persistent disengagement cues. Mothers are taught how to adapt ATVV as their infant grows. Fidelity to the intervention is checked with weekly phone calls and monthly study visits. Mothers also receive a daily text from REDCap to document an intervention frequency log.

Also known as: multisensory infant massage plus
Behavioral ATVV intervention

Mothers in the Attention Control group receive a similar amount of daily texts, weekly phone call and in-person study visit attention as mothers in the ATVV group, but with distinctly different content. Over the first 3 postnatal months, mothers learn safe infant-care that includes content on diapers, infant clothing, blankets, infant care including bathing, sleep positions, sleep habits, holding the baby, safety of infant equipment, breastfeeding, formula, and age appropriate toys.

Attention control

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Pregnant
  • Healthy (gestational diabetes is acceptable)
  • Greater than or equal to 18 years old
  • Nulliparous (previous miscarriage(s) and/or abortion(s) acceptable)
  • Speak and read English or Spanish
  • Score greater than or equal to 2 on the Adverse Childhood Experience (ACE) survey
  • Expect to deliver a healthy infant
  • Expect to deliver a full-term infant (greater than or equal to 37 weeks and 0/7 days)
  • Expect to deliver a singleton infant

You may not qualify if:

  • Multiparous
  • Have no access to a cell phone during the first 3 postnatal months
  • Carrying multiple fetuses
  • Taking anti-depressant(s) during pregnancy
  • Taking illicit drugs
  • Do not speak and read English or Spanish;
  • Under 18 years of age
  • Score less than 2 on the Adverse Childhood Experience (ACE) survey
  • Deliver an infant diagnosed with conditions that could affect normal development or the oxytocin system
  • Pre-term gestation (less than 37 weeks and 0/7 days)
  • Intrauterine growth retardation (IGR)
  • Small for gestational age (SGA)
  • Chromosomal anomaly including
  • Down syndrome (trisomy 21)
  • Trisomy 13
  • +11 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Tucson Medical Center

Tucson, Arizona, 85712, United States

Location

Banner University Medical Center - Tucson

Tucson, Arizona, 85719, United States

Location

Related Publications (1)

  • Jones KA, Freijah I, Brennan SE, McKenzie JE, Bright TM, Fiolet R, Kamitsis I, Reid C, Davis E, Andrews S, Muzik M, Segal L, Herrman H, Chamberlain C. Interventions from pregnancy to two years after birth for parents experiencing complex post-traumatic stress disorder and/or with childhood experience of maltreatment. Cochrane Database Syst Rev. 2023 May 4;5(5):CD014874. doi: 10.1002/14651858.CD014874.pub2.

MeSH Terms

Conditions

Infant Behavior

Condition Hierarchy (Ancestors)

Child BehaviorBehavior

Results Point of Contact

Title
Dr. Aleeca Bell
Organization
University of Arizona

Study Officials

  • Aleeca Bell, PhD

    University of Arizona, College of Nursing

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The video coders measuring mother-infant synchrony will be blinded to group assignment.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: This randomized clinical trial uses group comparison of an intervention group and an education control group.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

March 23, 2021

First Posted

March 26, 2021

Study Start

July 12, 2021

Primary Completion

March 8, 2024

Study Completion

June 17, 2024

Last Updated

August 13, 2025

Results First Posted

August 13, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations